🟢 HCW Biologics is trading 7% up today amid biotech-sector gains

HCW Biologics is trading at $1.33, up 7.26%, amid biotech-sector strength; no company-specific catalyst was identified.

• The price is up from the October 16 close of $1.24.
• No October 19 company-specific announcement was identified. The latest company release surfaced was October 9, describing FDA guidance for its lead cancer candidate and a planned first-half 2027 IND filing.
• Biotech shares gained 2.09% amid M&A interest and anticipation of cancer data; this is sector context, not a confirmed HCW Biologics-specific catalyst.